| 1 | 12:10-12:50 | 专题会 |
全球RSV预防策略和临床应用实践 |
|
||||
| 1 | 12:50-13:30 | 专题会 |
从药学视角看右哌甲酯缓释制剂在儿童ADHD中的应用 |
|
||||
| 1 | 13:30-13:35 | 致辞 |
临床药理分会场开幕式 |
|
||||
| 2 | 13:35-14:05 | 专题报告 |
关键营养素与出生缺陷研究 |
|
||||
| 1 | 14:05-14:35 | 专题报告 |
重症病毒性肺炎的病原学治疗 |
|
||||
| 1 | 14:35-15:05 | 专题报告 |
破解儿童安全用药困境:开展儿童药物临床试验是关键 |
|
||||
| 2 | 15:05-15:10 | 讨论 |
讨论 |
|||||
| 1 | 15:10-15:16 | 大会发言 |
基于个体化特征的儿童造血干细胞移植的精准药物治疗模式探索 |
|
||||
| 2 | 15:16-15:22 | 大会发言 |
Toward Precision Medicine in Pediatric ITP: A Real-World Cohort Study of Plasma-Guided Eltrombopag Dosing |
|
||||
| 3 | 15:22-15:28 | 大会发言 |
Therapeutic Drug Monitoring of Posaconazole Delayed-release Tablet and Injection in Pediatric Patients |
|
||||
| 4 | 15:28-15:34 | 大会发言 |
Comparing tacrolimus level monitoring in peripheral blood mononuclear cells and whole blood within one year after kidney transplantation: a single-center, prospective, observational study |
|
||||
| 1 | 15:34-15:40 | 大会发言 |
pharmacokinetics and pharmacodynamics of oral azithromycin therapy to clear the colonization of ureaplasma urealyticum in premature infants |
|
||||
| 2 | 15:40-15:46 | 大会发言 |
Efficacy and safety factors related to plasma concentration-optimized polymyxin B therapy in treating carbapenem-resistant gram-negative bacterial infections in China |
|
||||
| 3 | 15:46-15:52 | 大会发言 |
A Multicenter Randomized Controlled Study on Pharmacokinetic-guided Vancomycin Use in Children with Severe Infections |
|
||||
| 4 | 15:52-15:58 | 大会发言 |
基于机器学习的他克莫司剂量与疗效预测模型在儿童难治性肾病综合征中的临床应用:一项前瞻性研究 |
|
||||
| 5 | 15:58-16:03 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 16:03-16:33 | 专题报告 |
新生儿脑病的循证与个性化治疗 |
|
||||
| 1 | 16:33-17:03 | 专题报告 |
中国新生儿侵袭性细菌性感染常见病原菌和耐药趋势变化 |
|
||||
| 2 | 17:03-17:08 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 17:08-17:14 | 大会发言 |
氯巴占及代谢物浓度检测应用于耐药性癫痫儿童药物治疗的获益分析 |
|
||||
| 2 | 17:14-17:20 | 大会发言 |
Association between busulfan exposure and clinical outcomes following allogeneic haemopoietic cell transplantation in Chinese pediatric patients: A multicenter, retrospective study |
|
||||
| 3 | 17:20-17:26 | 大会发言 |
呼吸道解脲脲原体定植早产儿口服阿奇霉素群体药代动力学研究及剂量优化 |
|
||||
| 4 | 17:26-17:32 | 大会发言 |
量化儿童淋巴管畸形中西罗莫司安全性:基于BKMR-PopPK整合模型的暴露-反应框架助力个体化风险及给药剂量预测 |
|
||||
| 1 | 17:32-17:38 | 大会发言 |
Lipin1基因在丙戊酸致癫痫患儿肥胖中的调控机制及个体化给药 |
|
||||
| 2 | 17:38-17:44 | 大会发言 |
LC-MS/MS-based metabolomics and proteomics reveal the intervention of Kangnian Decoction on the postoperative intestinal adhesion of rats |
|
||||
| 3 | 17:44-17:50 | 大会发言 |
单细胞测序揭示肾移植受者抗体介导排斥反应的潜在机制 |
|
||||
| 4 | 17:50-18:00 | 讨论 |
集体答疑、讨论 |
|||||